Live Breaking News & Updates on Gray Strategic Advisors

Stay updated with breaking news from Gray strategic advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Compass Therapeutics Announces Appointment of Two New

BOSTON, April 26, 2022 (GLOBE NEWSWIRE) Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company. ....

United States , Carl Gordon , Mary Ann Gray , Thomasj Schuetz , Wilmer Cutler Pickering Hale , Ellen Chiniara , Vered Bisker Leib , Mary Ann , Danna Gifford , Alexion Pharmaceuticals , Kaufmann Fund , Gray Strategic Advisors , Keros Pharmaceuticals , Northwestern University Medical School , Sarepta Pharmaceuticals , Compass Therapeutics Inc , Yale University School Of Medicine , Abbott Laboratories , University Of Vermont , Chief Legal Officer , Gray Strategic , Chief Executive , Executive Vice President , Corporate Secretary , Corporate Social Responsibility , General Counsel ,

Compass Therapeutics, Inc (CMPX) Appoints Ellen Chiniara and Mary Ann Gray to its Board

Compass Therapeutics, Inc (CMPX) Appoints Ellen Chiniara and Mary Ann Gray to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Carl Gordon , Wilmer Cutler Pickering Hale , Ellen Chiniara , Mary Ann Gray , Mary Ann , Thomasj Schuetz , Alexion Pharmaceuticals , Kaufmann Fund , Gray Strategic Advisors , Keros Pharmaceuticals , Northwestern University Medical School , Sarepta Pharmaceuticals , Compass Therapeutics Inc , Yale University School Of Medicine , Abbott Laboratories , University Of Vermont , Wall Street , Chief Legal Officer , Gray Strategic , Chief Executive , Executive Vice President , Corporate Secretary , Corporate Social Responsibility , General Counsel , Chief Ethics ,

Keros Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors

Published: Dec 17, 2020
LEXINGTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that it appointed Mary Ann Gray, Ph.D., to its Board of Directors.
We are delighted to welcome Dr. Gray to Keros’ Board of Directors,” said President and Chief Executive Officer Jasbir Seehra, Ph.D. Her deep experience guiding both growing and commercial-stage companies as a board member, coupled with her scientific and financial acumen, will be a tremendous asset as we continue to further advance multiple assets in the clinic. ....

United States , Mary Ann Gray , Jasbir Seehra , Julia Balanova , Keros Therapeutics Inc , Kaufmann Fund , Company Nasdaq , Neorx Corporation , Gray Strategic Advisors , Rapt Therapeutics Inc , Northwestern University Medical School , Prior To Federated Kaufmann Fund , Bioatla Inc , University Of South Carolina , Yale University School Of Medicine , Sarepta Therapeutics Inc , Schering Plough Research , Seneca Biopharmaceuticals Inc , University Of Vermont , Kero Board , Chief Executive Officer Jasbir Seehra , Senior Analyst , Portfolio Manager , Federated Kaufmann Fund , Sarepta Therapeutics , Seneca Biopharmaceuticals ,

Keros Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors

Keros Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

United States , Mary Ann Gray , Jasbir Seehra , Julia Balanova , Keros Therapeutics Inc , Kaufmann Fund , Company Nasdaq , Neorx Corporation , Gray Strategic Advisors , Rapt Therapeutics Inc , Northwestern University Medical School , Prior To Federated Kaufmann Fund , Bioatla Inc , University Of South Carolina , Yale University School Of Medicine , Sarepta Therapeutics Inc , Schering Plough Research , Seneca Biopharmaceuticals Inc , University Of Vermont , Kero Board , Chief Executive Officer Jasbir Seehra , Senior Analyst , Portfolio Manager , Federated Kaufmann Fund , Sarepta Therapeutics , Seneca Biopharmaceuticals ,